Recall Register

Food, drugs, devices › Toshiba American Medical Systems Inc

Device recall: Toshiba America Medical Systems Ultimax Digital Fluoroscopic X-Ray System Model: DREX-UI80 Ultimax is intended for gastr

FDA enforcement event 77679 · Class II · initiated 15 Mar 2017 · status Terminated · terminated 25 Sep 2020

DeviceFDA Mandated1 product recordTustin, CA

FDA enforcement event 77679 is a device recall by Toshiba American Medical Systems Inc of Tustin, CA, initiated 15 Mar 2017 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 1,091 device enforcement events initiated in 2017 carry the same class.

Status: Terminated, terminated 25 Sep 2020. Initiation: fda mandated. Toshiba American Medical Systems Inc has 36 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Toshiba American Medical Systems Inc, Tustin, CA.

Reason for recall

"The issue was identified as a firmware problem with the generator."

Distribution

"US Distribution to the states of : LA, AR, IA, TX, IL, MN. MS, NJ, WV, SC, LA, WY, NC and CA."

Product records

Recall numberProductQuantityClassStatusReport date
Z-3070-2017Toshiba America Medical Systems Ultimax Digital Fluoroscopic X-Ray System Model: DREX-UI80 Ultimax is intended for gastrointestinal studies, vascular studies, general radiography, and fluoroscopy. The system has medical applications ranging from but not limited to: contrast-enhanced studies, support of endoscopic…18Class IITerminated6 Sep 2017

Context

93%of 2017 device events are Class II1,091 events that year
1product record in this eventfirm median: 1
36events on this register for the firm

Other enforcement events for Toshiba American Medical Systems Inc

InitiatedProduct (first record)TypeClassRecords
4 Jan 2018Diagnostic Ultrasound System, Aplio I-series. Labeled as i700, i800, i900 The power supply unit may be damaged and may fDeviceClass II1
29 Dec 2017INFX-8000F Fluoroscopic X-Ray SystemsDeviceClass II4
12 Sep 2017Toshiba Medical Kalare Fluoroscopic X-Ray System (DREX-KL80) Kalare is intended to be used as a universal diagnostic imaDeviceClass II1
1 May 2017XARIO 100 TUS-X100 diagnostic ultrasound systemDeviceClass II5
1 Feb 2017Angio WorkStation (XIDF-AWS801) used in conjunction with your Infinix System (INFX-8000V;INFX-8000C;INFX-8000FDeviceClass II1
25 Oct 2016Aquilion Prime TSX-303A Aquilion PRIME is a multislice helical CT system with an 40-row detector. High-speed rotation alDeviceClass II1
4 Aug 2016Xario 100 Diagnostic Ultrasound System, TUS-X100; Xario 200 Diagnostic Ultrasound System, TUS-X200.DeviceClass II1
19 May 2016Toshiba Kalare DREX-KL80 X-ray generatorDeviceClass II2
25 Apr 2016Toshiba America Medical Systems, Inc Aquilion Lightning TSX-035A CT Scanner.DeviceClass II4
24 Apr 2016Toshiba American Medical Systems Celesteion, Item Code: PCA-9000A/2, 9000A/3B, 9000A/2B This system is designed to acquiDeviceClass II1

All 36 events for Toshiba American Medical Systems Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The issue was identified as a firmware problem with the generator."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Distribution to the states of : LA, AR, IA, TX, IL, MN. MS, NJ, WV, SC, LA, WY, NC and CA."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 25 Sep 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.